The genetic landscape of 87 ovarian germ cell tumors-Reference-Cited by-同舟云学术

The genetic landscape of 87 ovarian germ cell tumors

Published:2018-10 Issue:1 Volume:151 Page:61-68
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Van Nieuwenhuysen Els,Busschaert Pieter,Neven Patrick,Han Sileny N.,Moerman Philippe,Liontos Michalis^ORCID,Papaspirou Maria,Kupryjanczyk Jolanta,Hogdall Claus,Hogdall Estrid,Oaknin Ana,Garcia Angel,Mahner Sven,Trillsch Fabian,Cibula David^ORCID,Heitz Florian,Concin Nicole,Speiser Paul,Salvesen Helga,Sehouli Jalid,Lambrechts Diether,Vergote Ignace

Funder

Fonds kiemceltumoren van het ovarium

Vriendtjes tegen Kanker

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference37 articles.

1. Malignant germ cell tumors of the ovary;Tewari;Obstet. Gynecol.,2000

2. Germ cell tumors of the ovary;Pectasides;Cancer Treat. Rev.,2008

3. Management of ovarian germ cell tumors;Gershenson;JCO,2007

4. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis;Kraggerud;Endocr. Rev.,2013

5. Development of malignant germ cells – the genvironmental hypothesis;Looijenga;Int. J. Dev. Biol.,2013

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors of 87 ovarian yolk sac tumor (OYST) patients and molecular characteristics of persistent and recurrent OYST;Gynecologic Oncology;2024-08

2. Dysgerminoma of the ovary;Minerva Obstetrics and Gynecology;2024-07

3. Assessment of Molecular Markers in Pediatric Ovarian Tumors: Romanian Single-Center Experience;International Journal of Molecular Sciences;2024-06-19

4. Malignant ovarian and testicular germ cell tumors: Common characteristics but different prognoses;Journal of Internal Medicine;2024-03-11

5. WTAP-mediated abnormal m6A modification promotes cancer progression by remodeling the tumor microenvironment: bibliometric and database analyses;Translational Cancer Research;2024-02